Pharmaceutical
ARIAD Pharmaceuticals, Inc. today announced that the Company and collaborating investigators from five major oncology research centers in the United States will present data from a Phase 1 clinical trial of ARIAD's investigational, multi-targeted ...
7 minutes ago
for the treatment of severe oral mucositis in patients with head and neck cancer. Topline results of the oral mucositis trial are expected to be announced in the first half of 2010.
26 minutes ago
RXi Pharmaceuticals Corporation , a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference , today reported that the Company has received Frost & Sullivan's 2009 North ...
27 minutes ago
NanoViricides, Inc. , announced today that Dr. Eugene Seymour, MD MPH, CEO of the Company, presented lifetime data from the recent FluCide animal study on November 19th at the Influenza Congress USA 2009 in Washington, DC . These data clearly ...
36 minutes ago
Spectrum Pharmaceuticals, Inc. , a commercial stage biotechnology company with a primary focus in oncology, and Handok Pharmaceuticals Co., Ltd., a fully integrated Korean pharmaceutical company, today announced a collaboration for the development ...
39 minutes ago
Human Genome Sciences, Inc. and Aegera Therapeutics, Inc. today announced that HGS has initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced ...
41 minutes ago
Atrium Medical Corporation announced that the 100th patient was enrolled in the iCAST Atrium Registry Ultrasound Study . The iCARUS study is a prospective, multi-center clinical trial studying the safety and efficacy of the Atrium iCAST Balloon ...
42 minutes ago
SciClone Pharmaceuticals, Inc. today announced that it will present at the upcoming Piper Jaffray Annual Healthcare Conference in New York City. Friedhelm Blobel, Ph.D., SciClone's President and Chief Executive Officer, will present a corporate ...
42 minutes ago
Provectus Pharmaceuticals, Inc. , a development-stage oncology and dermatology biopharmaceutical company, announced today that initial one year overall survival data from the first 20 subjects in the current Phase 2 trial showed comparable trends ...
42 minutes ago
MedPro Safety Products, Inc. , a pioneer in the development and marketing of passive needlestick injury prevention technology, today reported on the Company's recent progress.
71 minutes ago
Vical Incorporated announced today that the company has completed the last scheduled follow-up visit for the final patient enrolled in a Phase 2 trial of its TransVax cytomegalovirus vaccine in hematopoietic stem cell transplant recipients. The ...
72 minutes ago
Amarin Corporation plc announced today that it has sent to its shareholders a Notice of the Annual General Meeting of the Company, which will be held on December 21, 2009 in Dublin, Ireland.
87 minutes ago
Millipore Corporation , a leading provider of technologies, tools and services for the global life science industry, today announced it has acquired the remaining 60 percent ownership of its joint-venture in India, Millipore India Pvt. Ltd. The new ...
98 minutes ago
A.P. Pharma, Inc. , a specialty pharmaceutical company, today announced that, on November 19, 2009, the Company received notice from the Nasdaq Listing Qualifications Panel that it has regained compliance with the shareholders' equity requirement ...
102 minutes ago
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa clinical trial of IL-7 in support of tumor lysate/KLH pulsed ...
102 minutes ago
1 - 15 of 73688 Stories
<<
<
Next 15 Pharmaceutical
>
>>
Search News
Daily News
